- £251.12m
- £220.63m
- £460.00m
- 79
- 65
- 99
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 112 | 102 | 155 | 279 | 460 |
Cost of Revenue | |||||
Gross Profit | 5.49 | 7.67 | 15.2 | 44.1 | 83 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 118 | 103 | 152 | 273 | 422 |
Operating Profit | -5.9 | -1.57 | 3.49 | 5.93 | 38.1 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.98 | -1.54 | 3.39 | 5.84 | 39.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.97 | -1.17 | 4.45 | 4.77 | 30.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.97 | -1.17 | 4.45 | 4.77 | 30.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.97 | -1.17 | 4.45 | 4.77 | 30.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.29 | -0.072 | 0.28 | 0.262 | 1.69 |
Dividends per Share |